Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies

Iván Rodríguez-Pampín, Lucía González-Pico, Asier Selas, Antonio Andújar, Rubén Prieto-Díaz, Eddy Sotelo

Pharmacological Reviews, 77, 6, 2025, 100092 | https://doi.org/10.1016/j.pharmr.2025.100092